Utah’s business landscape is rich with professionals who have le...Read More
Social Media and Employers: Friends or Enemies?
The Case for HSAs
Time to Show Up
Make a Move
In the Lab
Rent to Own
Back from the Dead
A Breath of Fresh Air
Travel & Tourism
Salt Lake City – Myriad Genetics, Inc. has signed a three-year contract with UnitedHealthcare. The contract provides UnitedHealthcare with access for BRCA testing and the myRisk Hereditary Cancer test for patients who meet the hereditary cancer testing eligibility criteria.
Myriad's myRisk Hereditary Cancer test evaluates 25 clinically significant hereditary cancer genes associated with eight major hereditary cancers including: breast, colon, ovarian, endometrial, pancreatic, prostate, gastric cancers and melanoma.
"Myriad has been a pioneer in hereditary cancer testing for almost 20 years," said Mark Capone, president of Myriad Genetic Laboratories. "Through scientific research and innovation, Myriad is able to provide a significantly more comprehensive, next generation cancer test for hereditary cancer syndromes.